Refractive Surgery News

KIAWAH ISLAND, S.C. ― At Kiawah Eye 2017, Eric D. Donnenfeld, MD, discusses how the LipiScan from TearScience helps him show refractive cataract surgery patients the anatomy of the meibomian gland and meibomian gland disease. He says this has helped his practice improve the ocular surface before refractive cataract surgery for optimal visual outcomes.

MILAN — At the OSN Italy meeting, Roberto Zaldivar, MD, was awarded the Benedetto Strampelli SOI Medal Lecture. The topic focused on the evolution and future prospects of the STAAR phakic ICL, which he introduces in this video.

MILAN — At the OSN Italy meeting, Rolando Toyos, MD, emphasizes the importance of treating any ocular surface disturbance before cataract or LASIK surgery. He suggests options to deal with a problem that is increasingly widespread and can jeopardize results even in the hands of the most skilled surgeon and with the best equipment.

MILAN — Klaus Ditzen, MD, talks at the OSN Italy meeting about the outcomes, advantages and limitations of laser techniques for presbyopia. As a pioneer of refractive surgery, he gives his advice on best choices and pearls for best outcomes.

MILAN — Is there a role for mix and match now that multifocal lens technology has improved and the choice of lenses is wider? At the OSN Italy meeting, Magda Rau, MD, shares her views on this topic and her outcomes of a study.

The EVO+ Visian ICL with aspheric optic has received a CE mark for commercialization in the European Union, according to a STAAR Surgical press release.

PRK and femtosecond-assisted LASIK have equally mild and transient effects on the ocular surface, according to a study.

The aspheric Precizon Presbyopic IOL received a CE mark and will be commercially launched in October during the European Society of Cataract and Refractive Surgeons meeting in Lisbon, Portugal, Ophtec announced in a press release.

LOS ANGELES — Adding a toric platform to a multifocal IOL significantly improves vision at intermediate and near distances, according to one speaker.

LOS ANGELES — The new Bausch + Lomb enVista toric IOL met all safety and efficacy endpoints in a pivotal FDA trial, according to a presentation here.